Reduced cortical thickness is associated with the glutamatergic regulatory gene risk variant DAOA Arg30Lys in schizophrenia

Neuropsychopharmacology

Volumn 36, Issue 8, 2011, Pages 1747-1753

  Schultz, C Christoph ^a   Nenadic, Igor ^a   Koch, Kathrin ^a   Wagner, Gerd ^a   Roebel, Martin ^a   Schachtzabel, Claudia ^a   Mühleisen, Thomas W ^b   Nöthen, Markus M ^b   Cichon, Sven ^b,c   Deufel, Thomas ^a   Kiehntopf, Michael ^a   Rietschel, Marcella ^d   Reichenbach, Jürgen R ^a   Sauer, Heinrich ^a   Schlösser, Ralf G M ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c FORSCHUNGSZENTRUM JÜLICH   (Germany)

^d CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

cortical thickness; DAOA; G72; rs2391191; schizophrenia; susceptibility gene

Indexed keywords

ARGININE; GLUTAMIC ACID; LYSINE;

ADULT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DAOA GENE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LEFT HEMISPHERE; MAJOR CLINICAL STUDY; NEUROMODULATION; OCCIPITAL CORTEX; PARIETAL CORTEX; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATOR GENE; RIGHT HEMISPHERE; SCHIZOPHRENIA; TEMPORAL CORTEX; THICKNESS; VISION;

EID: 85027953437     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.56     Document Type: Article

References (58)

1. Andreasen NC, Calarge CA, O'Leary DS (2008). Theory of mind and schizophrenia: a positron emission tomography study of medication-free patients. Schizophr Bull 34: 708-719. (Pubitemid 351957558)
2. Annett M (1967). The binomial distribution of right, mixed and left handedness. Q J Exp Psychol 19: 327-333.
3. Bora E, Yucel M, Pantelis C (2009). Theory of mind impairment in schizophrenia: meta-analysis. Schizophr Res 109: 1-9.
4. Brune M, Lissek S, Fuchs N, Witthaus H, Peters S, Nicolas V et al (2008). An fMRI study of theory of mind in schizophrenic patients with 'passivity' symptoms. Neuropsychologia 46: 1992-2001.
5. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 99: 13675-13680. (Pubitemid 35215440)
6. Coleman MJ, Cestnick L, Krastoshevsky O, Krause V, Huang Z, Mendell NR et al (2009). Schizophrenia patients show deficits in shifts of attention to different levels of global-local stimuli: evidence for magnocellular dysfunction. Schizophr Bull 35: 1108-1116.
7. Coyle JT (2006). Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 26: 365-384.
8. Coyle JT, Tsai G (2004). NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int Rev Neurobiol 59: 491-515. (Pubitemid 39752426)
9. Coyle JT, Tsai G, Goff D (2003). Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann NY Acad Sci 1003: 318-327. (Pubitemid 38083065)
10. Dale AM, Fischl B, Sereno MI (1999). Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuro-image 9: 179-194. (Pubitemid 29369874)
11. Detera-Wadleigh S, McMahon F (2006a). G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 60: 106-114. (Pubitemid 44026593)
12. Detera-Wadleigh SD, McMahon FJ (2006b). G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 60: 106-114. (Pubitemid 44026593)
13. Di Perri C, Dwyer MG, Wack DS, Cox JL, Hashmi K, Saluste E et al (2009). Signal abnormalities on 1.5 and 3 Tesla brain MRI in multiple sclerosis patients and healthy controls. A morphological and spatial quantitative comparison study. Neuroimage 47: 1352-1362.
14. Donohoe G, Morris DW, Robertson IH, McGhee KA, Murphy K, Kenny N et al (2007). DAOA ARG30LYS and verbal memory function in schizophrenia. Mol Psychiatry 12: 795-796. (Pubitemid 47347797)
15. du Bois TM, Huang XF (2007). Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia. Brain Res Rev 53: 260-270.
16. Ettlinger G (1990). 'Object vision' and 'spatial vision': the neuropsy-chological evidence for the distinction. Cortex 26: 319-341. (Pubitemid 20313051)
17. Fischl B, Dale AM (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA 97: 11050-11055.
18. Fischl B, Sereno MI, Dale AM (1999). Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage 9: 195-207. (Pubitemid 29369875)
19. Fischl B, van der Kouwe A, Destrieux C, Halgren E, Segonne F, Salat DH et al (2004). Automatically parcellating the human cerebral cortex. Cereb Cortex 14: 11-22. (Pubitemid 38018050)
20. Fornito A, Yucel M, Wood SJ, Adamson C, Velakoulis D, Saling MM et al (2008). Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp 29: 478-489. (Pubitemid 351522140)
21. Gobbini MI, Koralek AC, Bryan RE, Montgomery KJ, Haxby JV (2007). Two takes on the social brain: a comparison of theory of mind tasks. J Cogn Neurosci 19: 1803-1814. (Pubitemid 350043423)
22. Green MF, Glahn D, Engel SA, Nuechterlein KH, Sabb F, Strojwas M et al (2005). Regional brain activity associated with visual backward masking. J Cogn Neurosci 17: 13-23.
23. Green MF, Nuechterlein KH, Breitmeyer B, Mintz J (2006). Forward and backward visual masking in unaffected siblings of schizophrenic patients. Biol Psychiatry 59: 446-451. (Pubitemid 43289225)
24. Habl G, Zink M, Petroianu G, Bauer M, Schneider-Axmann T, von Wilmsdorff M et al (2009). Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study. J Neural Transm 116: 1657-1665.
25. Hartz SM, Ho BC, Andreasen NC, Librant A, Rudd D, Epping EA et al (2010). G72 influences longitudinal change in frontal lobe volume in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 153B: 640-647.
26. Hashimoto K, Fukushima T, Shimizu E, Komatsu N, Watanabe H, Shinoda N et al (2003). Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch Gen Psychiatry 60: 572-576. (Pubitemid 36682314)
27. Heresco-Levy U, Javitt DC, Ebstein R, Vass A, Lichtenberg P, Bar G et al (2005). D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biol Psychiatry 57: 577-585. (Pubitemid 40409697)
28. Hilgetag CC, Barbas H (2005). Developmental mechanics of the primate cerebral cortex. Anat Embryol (Berl) 210: 411-417. (Pubitemid 41752601)
29. Hilgetag CC, Barbas H (2006). Role of mechanical factors in the morphology of the primate cerebral cortex. PLoS Comput Biol 2: e22.
30. Hulshoff Pol HE, Schnack HG, Bertens MG, van Haren NE, van der Tweel I, Staal WG et al (2002). Volume changes in gray matter in patients with schizophrenia. Am J Psychiatry 159: 244-250. (Pubitemid 34126901)
31. Huttenlocher PR, Dabholkar AS (1997). Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387: 167-178. (Pubitemid 27430343)
32. Jansen A, Krach S, Krug A, Markov V, Eggermann T, Zerres K et al (2009). A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe. Neuroimage 45: 1002-1008.
33. Javitt DC (2002). Glycine modulators in schizophrenia. Curr Opin Investig Drugs 3: 1067-1072. (Pubitemid 36277620)
34. Javitt DC (2007). Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 78: 69-108.
35. Javitt DC (2009). When doors of perception close: bottom-up models of disrupted cognition in schizophrenia. Annu Rev Clin Psychol 5: 249-275.
36. Kantrowitz JT, Butler PD, Schecter I, Silipo G, Javitt DC (2009). Seeing the world dimly: the impact of early visual deficits on visual experience in schizophrenia. Schizophr Bull 35: 1085-1094.
37. Kay SR, Fiszbein A, Opler LA (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261-276. (Pubitemid 18039085)
38. Kelemen O, Erdelyi R, Pataki I, Benedek G, Janka Z, Keri S (2005). Theory of mind and motion perception in schizophrenia. Neuropsychology 19: 494-500. (Pubitemid 41077131)
39. Krug A, Markov V, Krach S, Jansen A, Zerres K, Eggermann T et al (2011). Genetic variation in G72 correlates with brain activation in the right middle temporal gyrus in a verbal fluency task in healthy individuals. Hum Brain Mapp 32: 118-126.
40. Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F et al (2003). Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 60: 878-888. (Pubitemid 37122306)
41. Madeira C, Freitas ME, Vargas-Lopes C, Wolosker H, Panizzutti R (2008). Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res 101: 76-83.
42. Mossner R, Schuhmacher A, Wagner M, Quednow BB, Frommann I, Kuhn KU et al (2010). DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis. Eur Arch Psychiatry Clin Neurosci 260: 209-215.
43. Narr KL, Bilder RM, Toga AW, Woods RP, Rex DE, Szeszko PR et al (2005). Mapping cortical thickness and gray matter concentration in first episode schizophrenia. Cereb Cortex 15: 708-719. (Pubitemid 40696111)
44. Nesvag R, Lawyer G, Varnas K, Fjell AM, Walhovd KB, Frigessi A et al (2008). Regional thinning of the cerebral cortex in schizophrenia: effects of diagnosis, age and antipsychotic medication. Schizophr Res 98: 16-28. (Pubitemid 350235896)
45. O'Donovan M, Craddock N, Owen M (2009). Genetics of psychosis; insights from views across the genome. Hum Genet 126: 3-12.
46. Sacchi S, Bernasconi M, Martineau M, Mothet JP, Ruzzene M, Pilone MS et al (2008). pLG72 modulates intracellular D-serine levels through its interaction with D-amino acid oxidase: effect on schizophrenia susceptibility. J Biol Chem 283: 22244-22256.
47. Schultz CC, Koch K, Wagner G, Roebel M, Nenadic I, Schachtzabel C et al (2010a). Complex pattern of cortical thinning in schizophrenia: results from an automated surface based analysis of cortical thickness. Psychiatry Res 182: 134-140.
48. Schultz CC, Koch K, Wagner G, Roebel M, Schachtzabel C, Gaser C et al (2010b). Reduced cortical thickness in first episode schizophrenia. Schizophr Res 116: 204-209.
49. Schultz CC, Koch K, Wagner G, Roebel M, Schachtzabel C, Nenadic I et al (2010c). Psychopathological correlates of the entorhinal cortical shape in schizophrenia. Eur Arch Psychiatry Clin Neurosci 260: 351-358.
50. Schumacher J, Jamra RA, Freudenberg J, Becker T, Ohlraun S, Otte AC et al (2004). Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry 9: 203-207. (Pubitemid 38299535)
51. Soronen P, Silander K, Antila M, Palo OM, Tuulio-Henriksson A, Kieseppa T et al (2008). Association of a nonsynonymous variant of DAOA with visuospatial ability in a bipolar family sample. Biol Psychiatry 64: 438-442.
52. Sprong M, Schothorst P, Vos E, Hox J, van Engeland H (2007). Theory of mind in schizophrenia: meta-analysis. Br J Psychiatry 191: 5-13. (Pubitemid 47035175)
53. Treutlein J, Muhleisen TW, Frank J, Mattheisen M, Herms S, Ludwig KU et al (2009). Dissection of phenotype reveals possible association between schizophrenia and glutamate receptor delta 1 (GRID1) gene promoter. Schizophr Res 111: 123-130.
54. Tsai G, Yang P, Chung LC, Lange N, Coyle JT (1998). D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 44: 1081-1089. (Pubitemid 28547143)
55. Uhlhaas PJ, Millard I, Muetzelfeldt L, Curran HV, Morgan CJ (2007). Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later. J Psychopharmacol 21: 347-352. (Pubitemid 46934052)
56. Vollm BA, Taylor AN, Richardson P, Corcoran R, Stirling J, McKie S et al (2006). Neuronal correlates of theory of mind and empathy: a functional magnetic resonance imaging study in a nonverbal task. Neuroimage 29: 90-98. (Pubitemid 41828033)
57. Ward BD (2000). Simultaneous inference for FMRI data. AFNI 3dDeconvolve Documentation,. Medical College of Wisconsin: Milwaukee, Wisconsin.
58. Williams M (2009). Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges. Biochem Pharmacol 78: 1360-1365.